Novel chip-based diagnostic technology can detect individual viral antigens in nasal swab samples to identify the viruses that cause COVID-19 and flu with a single test
The test will be widely available to individuals through pharmacies and other locations in accordance with local guidelines and testing strategies
Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India
The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)
Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D
Collaboration follows successful acquisition and commercialization of Oxsed, an Oxford University Spin-out, to scale OxLAMP rapid COVID-19 test globally
A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen.
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
New findings pave way to potentially improved assessment of measurable residual disease in AML patients
New service reduces project time from months to weeks for biopharma customers
The research describes a new family of enzymes for pharmaceutical production
The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted
The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes
Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min
Dr. Boye Schnack Nielsen shares tips for running successful in situ hybridization assays as he provides insights on how RNA detection methods have evolved over time
The antigen test is used to detect the nucleocapsid protein antigen in SARS-CoV-2
Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction
Catch up on this on-demand webinar to learn about early and late-onset neonatal hypocalcemia diagnosis
